ProtocolProtocolsFree

Semaglutide: The Complete Protocol Guide

Everything you need to know about semaglutide (Ozempic/Wegovy) for weight management. Dosing titration schedules, managing side effects, dietary considerations, and realistic expectations.

18 min read
Share:
By Peptides.NYC Editorial TeamUpdated May 21, 2026
Educational content only — not medically reviewed. Consult a licensed healthcare provider before acting on anything here.

Educational content only. Not medical advice. The content creators are not doctors or medical professionals. Consult your healthcare provider before taking any action.

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist—a medication that mimics glucagon-like peptide-1, a hormone your body naturally produces in response to eating. Originally developed for type 2 diabetes, semaglutide has become one of the most effective tools available for weight management, with clinical trials demonstrating average weight loss of 15-17% of body weight.

Available under brand names including Ozempic (diabetes indication) and Wegovy (weight management indication), semaglutide works by enhancing your body's own satiety signals, reducing appetite, and slowing gastric emptying. Unlike stimulant-based weight loss approaches, semaglutide addresses the biological drivers of overeating rather than simply suppressing symptoms.

How Semaglutide Works

GLP-1 Receptor Activation

When you eat, your intestines release GLP-1, which signals to your brain that you're full and triggers insulin release. Semaglutide amplifies this natural process:

  • Brain satiety centers: Semaglutide acts on the hypothalamus and brainstem to reduce appetite and increase feelings of fullness
  • Delayed gastric emptying: Food stays in your stomach longer, prolonging satiety after meals
  • Insulin regulation: Enhanced insulin secretion when blood sugar rises, improved insulin sensitivity
  • Glucagon suppression: Reduces glucagon release, preventing excessive glucose production by the liver

Why It's So Effective

Natural GLP-1 has a half-life of only 2-3 minutes—it's rapidly broken down by enzymes. Semaglutide is engineered to resist this breakdown, giving it a half-life of approximately one week. This allows once-weekly dosing while maintaining consistent appetite suppression throughout the week.

Clinical Evidence

Semaglutide's efficacy is supported by the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program—one of the most rigorous weight management study programs ever conducted.

STEP 1 Results

The landmark trial published in the New England Journal of Medicine showed:

  • Average weight loss: 14.9% of body weight (vs. 2.4% with placebo)
  • Participants losing ≥10%: 69.1% (vs. 12% placebo)
  • Participants losing ≥20%: 32% (vs. 1.7% placebo)
  • Duration: 68 weeks

STEP 5: Two-Year Data

Long-term data from STEP 5 demonstrated sustained efficacy:

  • Weight loss maintained at 2 years: ~15% average
  • Metabolic improvements: Significant reductions in HbA1c, blood pressure, and lipids
  • Quality of life: Improved physical function scores

SELECT Trial: Cardiovascular Benefits

The SELECT trial showed semaglutide reduced major cardiovascular events by 20% in people with obesity but without diabetes—establishing benefits beyond weight loss alone.

Dosing Protocol

Semaglutide requires gradual dose escalation to minimize side effects. Rushing this process significantly increases gastrointestinal symptoms.

Standard Titration Schedule

WeeksWeekly DoseNotes
1-40.25 mgInitiation dose—minimal weight loss expected
5-80.5 mgBegin to notice appetite reduction
9-121.0 mgSignificant appetite suppression
13-161.7 mgApproaching target dose
17+2.4 mgFull maintenance dose

Titration Tips

  • Don't rush: Each dose increase should feel manageable before moving up
  • Extended titration is okay: Some people need 6-8 weeks at each dose
  • Lower maintenance is fine: Many achieve goals at 1.0-1.7 mg without reaching 2.4 mg
  • Dose reduction for tolerance: If side effects are severe, dropping back one level temporarily is acceptable

Administration

Injection Technique

  1. Choose injection site: abdomen (most common), thigh, or upper arm
  2. Clean area with alcohol swab
  3. Pinch skin if using abdomen or thigh
  4. Insert pen needle at 90-degree angle
  5. Press and hold injection button for 6-10 seconds
  6. Remove needle and dispose properly

Timing Considerations

  • Same day each week: Consistency helps maintain steady levels
  • Any time of day: With or without food
  • Missed dose: If within 5 days of scheduled dose, take immediately. If more than 5 days, skip and resume regular schedule.

Managing Side Effects

Gastrointestinal side effects are common, especially during titration, but typically improve over time.

Nausea (Most Common)

Prevention and management:

  • Eat smaller, more frequent meals
  • Avoid fatty, greasy, or spicy foods
  • Stay well-hydrated
  • Eat slowly and stop when satisfied (not full)
  • Ginger tea or supplements may help
  • Consider dose reduction if severe

Constipation

Management:

  • Increase fiber intake gradually
  • Drink adequate water (aim for 64+ oz daily)
  • Consider magnesium citrate supplement
  • Increase physical activity
  • Fiber supplements (psyllium husk) if needed

Other Common Effects

  • Diarrhea: Usually transient; stay hydrated
  • Abdominal pain: Often improves with smaller meals
  • Fatigue: May occur initially; usually resolves
  • Injection site reactions: Rotate sites; usually mild

Serious Side Effects (Seek Medical Attention)

  • Severe, persistent abdominal pain (possible pancreatitis)
  • Signs of thyroid tumors: neck mass, difficulty swallowing, hoarseness
  • Severe allergic reactions
  • Signs of gallbladder problems: upper right abdominal pain, fever, jaundice

Nutrition Optimization

Semaglutide reduces appetite significantly—this is both its mechanism and its challenge. Ensuring adequate nutrition despite reduced intake is critical.

Protein Priority

The reduced caloric intake on semaglutide can accelerate muscle loss if protein is inadequate:

  • Target: 0.7-1.0 grams protein per pound of goal body weight
  • Example: 150 lb goal weight = 105-150g protein daily
  • Spread intake: 25-40g per meal across 3-4 meals
  • Protein-first eating: Start meals with protein before other foods

Practical Strategies

  • Track protein: Use an app to ensure adequate intake
  • Protein supplements: Whey, casein, or plant-based powders fill gaps
  • High-protein snacks: Greek yogurt, cottage cheese, jerky, protein bars
  • Prioritize whole foods: Fish, poultry, lean meat, eggs, legumes

Micronutrient Considerations

Reduced food intake means reduced micronutrient intake:

  • Consider a quality multivitamin
  • Monitor iron, B12, and vitamin D (common deficiencies)
  • Bloodwork at baseline and 12 weeks helps identify gaps

Exercise Recommendations

Exercise enhances semaglutide's effects and helps preserve muscle mass during weight loss.

Resistance Training (Critical)

  • Frequency: 2-4 sessions per week
  • Focus: Compound movements (squats, deadlifts, rows, presses)
  • Purpose: Preserve and build lean mass during weight loss
  • Intensity: Progressive overload—gradually increase weight/reps

Cardiovascular Exercise

  • Frequency: 150+ minutes moderate activity weekly
  • Types: Walking, cycling, swimming, rowing
  • Purpose: Cardiovascular health, additional calorie expenditure
  • Note: Don't over-rely on cardio; resistance training is more important for body composition

Activity Considerations

  • Start slowly: Energy may be lower initially
  • Listen to your body: Adjust intensity as needed
  • Non-exercise activity: Daily steps, taking stairs, walking meetings

Monitoring and Bloodwork

Baseline Testing

Before starting semaglutide, establish:

  • Complete metabolic panel
  • Lipid panel
  • HbA1c (even without diabetes)
  • Thyroid panel (TSH)
  • Liver function tests

Follow-Up Testing (12 weeks)

Repeat baseline labs plus:

  • Kidney function (especially if on other medications)
  • Monitor for nutritional deficiencies

Weight Tracking

  • Weigh weekly under consistent conditions
  • Track trends, not daily fluctuations
  • Expect plateaus—they're normal
  • Average loss: 1-2 lbs per week

Who Should Consider Semaglutide

Semaglutide may be appropriate for:

  • BMI ≥30 (obesity)
  • BMI ≥27 with weight-related health conditions (hypertension, type 2 diabetes, dyslipidemia)
  • Those who have tried lifestyle interventions without adequate success
  • Individuals seeking medically-supervised weight management

Who Should Avoid Semaglutide

Semaglutide is contraindicated or requires caution in:

  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis
  • Severe gastrointestinal disease
  • Pregnancy or planning pregnancy
  • Breastfeeding

Frequently Asked Questions

How long before I see weight loss results? Most people notice reduced appetite within the first 1-2 weeks. Meaningful weight loss typically begins around weeks 4-8 as doses increase. Maximum effect is usually reached at the maintenance dose after 16-20 weeks.

Will I regain weight if I stop semaglutide? Studies show weight regain is common after discontinuation—approximately two-thirds of lost weight may return within one year without intervention. This reflects semaglutide's action on biological appetite regulation. Long-term use or robust lifestyle changes help maintain results.

Can I drink alcohol on semaglutide? Moderate alcohol consumption is generally acceptable, but be aware that alcohol tolerance may be reduced, and alcohol provides empty calories that slow progress. Avoid excessive drinking, which increases pancreatitis risk.

How is compounded semaglutide different from brand-name? Compounded semaglutide from compounding pharmacies may differ in formulation, though it contains the same active ingredient. Discuss options with your healthcare provider to understand the differences.

Does semaglutide cause muscle loss? All caloric deficits can lead to some muscle loss. Adequate protein intake (0.7-1g per pound of goal weight) and resistance training significantly reduce this risk. Studies show muscle loss on semaglutide is proportional to weight loss—not excessive.

The Bottom Line

Semaglutide represents a significant advancement in weight management—clinical trials demonstrate efficacy beyond any previously available medication. By working with your body's natural satiety hormones rather than against them, it offers a sustainable approach to weight loss for many people who haven't succeeded with lifestyle changes alone.

However, semaglutide is not a magic solution. Optimal results require attention to nutrition (especially protein), regular exercise (especially resistance training), and ongoing medical supervision. For those who commit to these supporting strategies, semaglutide can be a powerful tool for achieving and maintaining meaningful weight loss.

Not medically reviewed

This content is produced by the Peptides.NYC editorial team from published research. It has not been reviewed by a licensed clinician and is educational only — always consult your healthcare provider before starting, stopping, or adjusting any peptide protocol.

Written By

Editorial team. We cite published research; we are not licensed clinicians and content is not medically reviewed.

Peptide researchHealth writingEvidence synthesis

This article cites peer-reviewed research and medical literature. Click any reference to view the original source.

  1. 1

    Wilding JPH, Batterham RL, et al. (2021) Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) New England Journal of Medicine.

    PMID: 33567185DOI: 10.1056/NEJMoa2032183View on PubMed
  2. 2

    Garvey WT, Batterham RL, et al. (2022) Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5) Nature Medicine.

    PMID: 35668336DOI: 10.1038/s41591-022-01877-1View on PubMed
  3. 3

    Lincoff AM, Brown-Frandsen K, et al. (2023) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) New England Journal of Medicine.

    PMID: 37952131DOI: 10.1056/NEJMoa2307563View on PubMed
  4. 4

    Rubino D, Abrahamsson N, et al. (2021) Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4) JAMA.

    PMID: 33755728DOI: 10.1001/jama.2021.3224View on PubMed
  5. 5

    Shi Q, Wang Y, et al. (2022) Efficacy and safety of semaglutide for weight management: a meta-analysis Obesity Reviews.

    PMID: 35543421DOI: 10.1111/obr.13451View on PubMed

Medical Disclaimer

The information on this website is for educational purposes only and is not medical advice. The content creators are not doctors or medical professionals. This content should not be used to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before starting any new supplement, medication, or health protocol. You assume all risks associated with using this information.